19/07/2012
This article was translated by an automatic translation system, and was therefore not reviewed by people.
Medication should be combined with a healthy lifestyle, including low-calorie diet and exercise
The FDA (Food and Drug Administration United States) gave the green light on Tuesday for the sale of Qnexa, a drug against obesity Vivus American laboratory. Janet Woodcock, director of the Center for drug evaluation and research at the FDA, said:
- Qnexa, used responsibly in combination with a healthy lifestyle that includes a low calorie diet and exercise, is an option for those dealing with chronic overweight in the United States.
Source: Journal of Health
Our news are taken in full of our partner sites. For this reason, we can not change the content of these up in case of typing errors.
This article was translated by an automatic translation system, and was therefore not reviewed by people.